Kellner Capital’s Aerie Pharmaceuticals AERI Stock Holding History

Kellner Capital’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-124,575	Closed	-$1.89M	–	39
2022 Q3	$1.89M	Buy	+124,575	New	+$1.45M	1.07%	25

Kellner Capital's AERI Position: Q4 2022 in Review

Kellner Capital sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 124,575 shares — an estimated $1.89M sold.

Kellner Capital first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $1.89M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Kellner Capital reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Kellner Capital sold 124,575 Aerie Pharmaceuticals shares in Q4 2022, an estimated $1.89M.
Kellner Capital first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
Kellner Capital's Aerie Pharmaceuticals position peaked at $1.89M in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Kellner Capital's 13F filing for Q4 2022, filed 13 Feb 2023.